Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 02/29/16
Due: 02/28/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791 | NCT02370043 | Kaneq Bioscience Limited | user2@example.com | None | 2015-02-28 | 2015-07-31 | 2016-07-31 | - | - | 2025-07-14 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus | NCT02445911 | Kaneq Bioscience Limited | user2@example.com | None | 2015-06-30 | 2016-02-29 | 2017-02-28 | - | - | 2025-07-14 |